Tumor-Specific Genetic Profiling and Therapy in Biomedicine

dc.contributor.author Uzuner,E.
dc.contributor.author Kiraz,Y.
dc.contributor.author Baran,Y.
dc.date.accessioned 2024-09-24T15:54:15Z
dc.date.available 2024-09-24T15:54:15Z
dc.date.issued 2020
dc.description.abstract Cancer cells divide continuously without any control, rendering immortal cells. These changes cause the dynamic instability in their genomes. Therefore each cancer cell in a tumor mass has various changes for specific tumor types. Their differences should be diagnosed on the basis of mutated genes and/or proteins. After the detection of alterations in cancer cells based on the techniques and instruments of biomedicine, personalized therapy continues with preexisting drug implementations. Personalized therapy broadens the borders with circulating tumor cells causing the metastasis in distant regions, developing specific gene therapies, novel targeted drugs, and immunotherapeutics for eliminating cancerous cells precisely. Within this context, biomedicine helps humankind to merge the biological and physiological knowledge to clinical practice. In this chapter, we aimed to clarify attitudes in biomedicine from molecular changes from single tumor cells to in vivo studies to find the best therapy for a cancer patient. © 2020 Elsevier Inc. All rights reserved. en_US
dc.identifier.doi 10.1016/B978-0-12-819541-3.00023-2
dc.identifier.isbn 978-012819541-3
dc.identifier.scopus 2-s2.0-85147599383
dc.identifier.uri https://doi.org/10.1016/B978-0-12-819541-3.00023-2
dc.identifier.uri https://hdl.handle.net/11147/14763
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartof Biodiversity and Biomedicine: Our Future en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject cancer-cell specific sequencing en_US
dc.subject circulating tumor cells en_US
dc.subject drug implementations en_US
dc.subject gene therapies en_US
dc.subject genetic profiling en_US
dc.subject genetic tests en_US
dc.subject immunotherapies en_US
dc.subject marker-based drug therapies en_US
dc.subject personalized therapies en_US
dc.subject Tumor-specific changes en_US
dc.title Tumor-Specific Genetic Profiling and Therapy in Biomedicine en_US
dc.type Book Part en_US
dspace.entity.type Publication
gdc.author.scopusid 57242876200
gdc.author.scopusid 56422406900
gdc.author.scopusid 9636164400
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::book::book part
gdc.collaboration.industrial false
gdc.description.department Izmir Institute of Technology en_US
gdc.description.departmenttemp Uzuner E., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey; Kiraz Y., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey; Baran Y., İzmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, İzmir, Turkey en_US
gdc.description.endpage 485 en_US
gdc.description.publicationcategory Kitap Bölümü - Uluslararası en_US
gdc.description.scopusquality N/A
gdc.description.startpage 459 en_US
gdc.description.wosquality N/A
gdc.identifier.openalex W3044688727
gdc.index.type Scopus
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.635068E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 1.6821013E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.16
gdc.opencitations.count 0
gdc.plumx.mendeley 10
gdc.plumx.scopuscites 0
gdc.scopus.citedcount 0
relation.isAuthorOfPublication.latestForDiscovery 7bb863bb-9384-4a07-9fbb-b9c1ab7634a3
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4003-8abe-a4dfe192da5e

Files